The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

CR/CRh rate of 23% in pivotal Ph 2 cohort of R/R NPM1-m AML patients - - Consistent efficacy with comparable CR/CRh rates and clinically meaningful MRD-negative responses across ...

The integration of artificial intelligence (AI) into fundus cameras presents a significant opportunity for market growth. AI algorithms demonstrate high accuracy in detecting diseases like diabetic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

You expired, Jesus, but the source of life gushed forth for souls and the ocean of mercy opened up for the whole world. O Fountain of Life, unfathomable Divine Mercy, cover the whole world and ...